ExtremoChem Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
- Investors
-
1
ExtremoChem General Information
Description
Operator of a chemical synthesis company intended to focus on the development and commercialization of novel small synthetic molecules for the stabilization of biologicals under stress conditions. The company offers a wide range of services including accelerated stability studies, pH stability assessment, thermal stability assessment, aggregation analysis, synthetic routes research and many more, enabling life science research organizations, pharmaceutical, biotech, agrochemical and chemical industries to stabilize medicines and proteins that are unstable at room temperature to store and stabilize at room temperature.
Contact Information
Website
www.extremochem.comCorporate Office
- Edifício Arcis
- Rua Ivone Silva, 6, 4 degree piso
- Lisbon, 1050-124
- Portugal
Corporate Office
- Edifício Arcis
- Rua Ivone Silva, 6, 4 degree piso
- Lisbon, 1050-124
- Portugal
ExtremoChem Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 16-Nov-2023 | Completed | Generating Revenue | |||
| 3. Grant | 31-Aug-2017 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 23-Dec-2013 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2013 | Completed | Startup |
ExtremoChem Patents
ExtremoChem Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2021502422-A | Neutral glycosylated amides and dianionic glucuron-oxidized acids as biomolecular stabilizers | Pending | 13-Nov-2017 | ||
| JP-2026133393-A | Neutral glycosylated amides and dianionic glucuron-oxidized acids as biomolecule stabilizers | Pending | 13-Nov-2017 | ||
| JP-7853339-B2 | Neutral glycosylated amides and dianionic glucuron-oxidized acids as biomolecule stabilizers | Active | 13-Nov-2017 | ||
| CA-3082696-A1 | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules | Active | 13-Nov-2017 | ||
| EP-3710463-A1 | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules | Pending | 13-Nov-2017 | C07H15/04 |
ExtremoChem Signals
ExtremoChem Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Acelerador de Comercialização de Tecnologias | Accelerator/Incubator | Minority | ||
| Horizon 2020 | Government |
ExtremoChem FAQs
-
When was ExtremoChem founded?
ExtremoChem was founded in 2013.
-
Where is ExtremoChem headquartered?
ExtremoChem is headquartered in Lisbon, Portugal.
-
What is the size of ExtremoChem?
ExtremoChem has 6 total employees.
-
What industry is ExtremoChem in?
ExtremoChem’s primary industry is Specialty Chemicals.
-
Is ExtremoChem a private or public company?
ExtremoChem is a Private company.
-
What is ExtremoChem’s current revenue?
The current revenue for ExtremoChem is .
-
Who are ExtremoChem’s investors?
Acelerador de Comercialização de Tecnologias and Horizon 2020 have invested in ExtremoChem.
-
When was ExtremoChem acquired?
ExtremoChem was acquired on 16-Nov-2023.
-
Who acquired ExtremoChem?
ExtremoChem was acquired by Hovione.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process